Back to Authors

Blair, Janis E.

https://orcid.org/0000-0003-2267-1473

Mayo Clinic

Mayo Clinic in Arizona

Citations 79

Comparison of two FDA-cleared EIA assays for the detection of Coccidioides antibodies against a composite clinical standard
Grys, Thomas E. , Brighton, Anjuli, Liesman, Rachael M. , LaSalle, Cassie Bolster, Blair, Janis E. , Bolster LaSalle, Cassie, Grys, Thomas E , Chang, Yu‐Hui

Medical Mycology | September 11, 2018 | Volume: 57 | Issue: 5 | Pages: 595-600

10.1093/mmy/myy094 Get It

The Utility of Screening for Coccidioidomycosis in Recipients of Inhibitors of Tumor Necrosis Factor α
Choi, Kristal, Deval, Neha, Vyas, Anuj, Moran, Conor , Cha, Stephen S, Mertz, Lester E., Pasha, Shabana F., Yiannias, James A. , Blair, Janis E. , Cha, Stephen S

Clinical Infectious Diseases | August 1, 2018 | Volume: 68 | Issue: 6 | Pages: 1024-1030

10.1093/cid/ciy620 Get It

Musculoskeletal coccidioidomycosis
Belthur, Mohan V. , Blair, Janis E. , Shrader, M. Wade , Malone, Jason

Current Orthopaedic Practice | June 27, 2018 | Volume: 29 | Issue: 4 | Pages: 400-406

10.1097/bco.0000000000000652 Get It

Coccidioidomycosis is an invasive fungal infection caused by the inhalation of aerosolized spores of Coccidioides spp., which reside in the arid soil of the southwestern United States and northern Mexico. The primary infection occurs in the lungs; however, less than 40% of patients are symptomatic. Dissemination of coccidioidomycosis is rare (1-5%), but can lead to extra pulmonic disease involving any organ. Skeletal coccidioidomycosis occurs in 10% to 50% of disseminated infections. Skeletal coccidioidomycosis is a chronic and progressive infection that eventually results in bone destruction and loss of function and often involves adjacent structures such as joints, muscles, tendons and other soft tissues. This infection is frequently multifocal with axial skeletal involvement. Although radiographs and other imaging methods identify relevant abnormalities, histopathologic examination with culture of the involved bone is the only means to confirm the diagnosis. Serologic testing is adjunctive, and complement fixation titers can be evaluated serially to assess response to treatment. Skeletal coccidioidomycosis is difficult to treat, and a combination of medical therapy and surgical debridement often is needed. Early diagnosis and treatment are critical to avoid long-term problems.
Coccidioidomycosis in selected immunosuppressed hosts
Blair, Janis E. , Ampel, Neil M. , Hoover, Susan E.

Medical Mycology | March 8, 2018 | Volume: 57 | Issue: Supplement_1 | Pages: S56-S63

10.1093/mmy/myy019 Get It

Single‐center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area
Lohrmann, Graham , Vucicevic, D., Lawrence, Romy, Steidley, D. Eric , Scott, Robert L. , Kusne, Shimon , Blair, Janis E. , Lohrmann, Graham M, Vucicevic, Darko

Transplant Infectious Disease | July 11, 2017 | Volume: 19 | Issue: 5 | Pages: No page available

10.1111/tid.12744 Get It

AbstractIn endemic regions, coccidioidomycosis causes substantial morbidity and mortality for patients receiving solid organ transplants. We aimed to demonstrate the effect of antifungal coccidioidal prophylaxis in heart transplant (HT) recipients. We retrospectively reviewed the electronic health records of all patients who received HTs between October 19, 2005, and December 13, 2014. We collected information regarding antifungal regimens and determined whether patients subsequently developed infections. Our 174‐person cohort all received antifungal prophylaxis for at least 6 months (mean follow‐up, 53.8 months). One proven and one probable coccidioidal infection (each, 0.6%) occurred during the study period. The incidence of coccidioidomycosis was 0.6% at 1 year and 2.3% at 5 years. No cases of proven coccidioidomycosis occurred within 2 years after transplantation. No patients developed disseminated disease, and no sentinel events were attributed to coccidioidomycosis. Both fluconazole and voriconazole were well tolerated. In the absence of intolerance or contraindication, we suggest continuing a universal antifungal prophylactic regimen with fluconazole for at least 6‐12 months in HT recipients residing in a coccidioidomycosis‐endemic area.
Oxygen Consumption Deficits in Patients With Residual Fatigue After Primary Coccidioidomycosis
Ganley, Kathleen J., Bosch, Pamela R. , Blair, Janis E. , Rischard, Franz , Galgiani, John N. , Rischard, Franz P

Open Forum Infectious Diseases | June 26, 2017 | Volume: 4 | Issue: 3 | Pages: No page available

10.1093/ofid/ofx136 Get It

Abstract Patients with coccidioidomycosis often report prolonged and debilitating fatigue after other evidence of infection has resolved. In this study, we quantify fatigue, muscle weakness, and impaired aerobic capacity in 5 such individuals. A closer examination of the cardiorespiratory system may contribute to a better understanding of underlying mechanisms and potential interventions.
Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
Blair, Janis E. , Wang, Sharon, Bercovitch, Robert, Bolaris, Michael , Akker, Dane Van Den, Heidari, Arash , Catanzaro, Antonino , Chin‐Hong, Peter , Spellberg, Brad , Johnson, Royce H. , Thompson, George R , López, Rodrigo , Cadena, José

Clinical Infectious Diseases | April 10, 2017 | Volume: 65 | Issue: 2 | Pages: 338-341

10.1093/cid/cix318 Get It

Culture-Proven Thorn-Associated Infections in Arizona: 10-Year Experience at Mayo Clinic
Simmons, Sierra C. , Budavari, Adriane I., Kusne, Shimon , Zhang, Nan , Vikram, Holenarasipur R. , Blair, Janis E. , Vikram, Holenarasipur R.

Open Forum Infectious Diseases | February 10, 2017 | Volume: 4 | Issue: 1 | Pages: No page available

10.1093/ofid/ofx017 Get It

AbstractBackgroundThorn injuries are common in the desert Southwest; however, the frequency and microbiology of thorn-associated infections have not been systematically described. Most information comes from case reports describing infections from atypical or environmental microorganisms. Our aim was to summarize the spectrum of thorn-associated infections.MethodsWe conducted a retrospective review of electronic health records for patients presenting to our institution from January 1, 2005 to December 31, 2014 for treatment of thorn-associated injuries and then focused on the patients with cultures.ResultsOf 2758 records reviewed, 1327 patients had thorn-associated injuries; however, only 58 (4.4%) had cultures. Of these patients, 37 (64%) had positive findings; 5 had polymicrobial infection. The most commonly identified organisms were Staphylococcus aureus (n = 22, 59.0%) and coagulase-negative Staphylococcus species (n = 8, 21.6%). Other pathogens included Nocardia species (n = 3, 8.1%), Streptococcus species (n = 2, 5.4%), Gram-negative bacteria (n = 2, 5.4%), Aspergillus species (n = 2, 5.4%), Paecilomyces lilacinus (n = 1, 2.7%), and Candida species (n = 1, 2.7%). There were no infections caused by Pantoea agglomerans, Sporothrix schenckii, or Coccidioides spp.ConclusionsIn contrast to most published case reports, we found that typical cutaneous microorganisms, such as Staphylococcus species, caused the majority of culture-positive, thorn-related infections.
The Utility of Screening for Coccidioidomycosis in Recipients of Anti-TNF-α Therapy.
Choi, Kristal, Mertz, Lester E., Heigh, Russell I., Yiannias, James A. , Blair, Janis E.

Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1277 Get It

1459Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
Wang, Sharon, Bercovitch, Robert, Bolaris, Michael , Akker, Dane Van Den, Catanzaro, Antonio, Zuluaga, Jose Cadena, Chin‐Hong, Peter , Spellberg, Brad , Blair, Janis E. , Johnson, Royce H. , Thompson, George R , López, Rodrigo , Heidari, Arash

Open Forum Infectious Diseases | February 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S384-S385

10.1093/ofid/ofu052.1005 Get It